Questions?

Click here to find the answers to the most frequently asked questions about ACC.17!

Contact the ACC Registration and Housing Center

  • (888) 322-2878
    (toll-free)
  • (847) 996-5822 (International)
  • M-F, 9:00 a.m. - 6:00 p.m. ET
  • acc@experient-inc.com
  • ACC.17 Grantor Acknowledgments

    Acute and Stable Ischemic Heart Disease Pathway

    Supported by educational grants from:

    Abbott Vascular
    Chiesi USA, Inc.
    Medtronic, Inc.

    Arrhythmia and Clinical EP Pathway

    Supported by educational grants from:

    Abbott Vascular
    Biosense Webster, Inc.
    Boston Scientific Corporation
    Bristol Myers Squibb and Pfizer, Inc.
    St. Jude Medical

    Heart Failure and Cardiomyopathies Pathway

    Supported by educational grants from:

    Abbott Vascular
    Amgen Inc.
    Novartis Pharmaceuticals Corporation

    Interventional Cardiology Pathway

    Supported by educational grants from:

    Abbott Vascular
    Boston Scientific Corporation
    Chiesi USA, Inc.
    Edwards Lifesciences
    Medtronic, Inc.

    Non-Invasive Imaging Pathway

    Supported by educational grants from:

    Abbott Vascular
    Astellas
    GE Healthcare Inc.
    Lantheus Medical Imaging

    Prevention Pathway

    Supported by educational grants from:

    Abbott Vascular
    Merck & Co.

    Pulmonary Hypertension and VTE Pathway

    Supported by educational grants from:

    Abbott Vascular
    Actelion Pharmaceuticals
    Bayer HealthCare Pharmaceuticals Inc.

    Valvular Heart Disease Pathway

    Supported by educational grants from:

    Abbott Vascular
    Edwards Lifesciences
    Medtronic, Inc.

    Vascular Medicine Pathway

    Supported by educational grants from:

    Abbott Vascular


    *Grantors as of March 13, 2017

    ACC.17 Clinical Focus Session Grantor Acknowledgments

    Breakthrough Therapies: Your Role in Protecting the Heart of Your Patients with Diabetes

    Supported by educational grants from:

    Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
    Novo Nordisk Inc.

    Complex Decisions in Mitral Valve Care: Individualizing Assessment, Diagnosis, and Treatment

    Supported by educational grants from:

    Abbott Vascular

    The Great “K” Debate Continues: Updates and Controversies in Heart Failure Management

    Supported by educational grants from:

    ZS Pharma, Inc.

    The Next Steps to Optimal Medical Therapy for Heart Failure Patients

    Supported by educational grants from:

    Novartis Pharmaceuticals Corporation

    Recent Trends in Combination Therapy: Managing Cholesterol Even in the Most Resistant

    Supported by educational grants from:

    Amgen Inc.
    Merck & Co.
    Sanofi US and Regeneron Pharmaceuticals


    *Grantors as of March 2, 2017

    Advertisement

    ACC Logo
    ACC.17 on Social Media:
          
    2017 American College of Cardiology Foundation. Visit ACC.org
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us